DOCSLIB.ORG

Measles & Rubella Initiative: 2016 Annual Summary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Measles & Rubella Initiative: 2016 Annual Summary TheMeasles & Rubella Initiative Logo Specication Logotype with “disappearing dots” Color Red color specication R:196 C:0 FINANCIALS EXECUTIVE SUMMARY G:20 M:100 B:37 Y:90 K:20 Cumulative Donations 2001 to 2016 = USD 1.2 Billion 2016 was a year of victory and challenge in Black Total contributions to M&RI by year: the global fight against measles and rubella. 2016 ANNUAL Clear space to leave around logo From 2000 through the end of 2015, measles vaccines saved community volunteers – the real heroes in this battle – with an estimated 20.3 million lives. All six WHO regions – including the tools and training they need to identify and embrace each Millions USD x all 194 WHO Member States – have committed to eliminating unreached and underserved child. While we work on strength- Reverse x square height = x 200 measles. In September 2016, the Americas became the first ening national immunization delivery systems, we must also SUMMARY region to be declared free of endemic measles. This, along continue to support countries – both financially and technically with its declaration of rubella elimination in 2015, makes the – to carry out well-planned and managed mass immunization Americas the first region to be free of endemic measles and campaigns. During 2016, 135 million children received measles 150 rubella. Before his death in 2014, Dr. Ciro De Quadros, who or measles-rubella vaccines in campaigns. During 78% of x x was one of the first to envision a measles and rubella-free campaigns, other public health interventions were delivered world, said, “Medicine, sanitation, nutrition, education – all in addition to measles or measles-rubella vaccine. are necessary and interrelated components of preventing and Reverse 100 curing sickness. But there is one tool that stands out as the But we cannot forget that mass campaigns are supplemental with dots most effective: vaccines. Every child – no matter where he immunization activities and, as such, must be used to @ 50% or she is born – has a fundamental right to vaccines.1” strengthen immunization delivery systems. M&RI has more transparent work to do on this front. Campaigns must be multifaceted to for eect 50 Imagine what he’d say now. raise awareness of the importance of on-time delivery of safe and effective vaccines, secure high-level government The support we provide to countries implementing ownership of and involvement in protecting their children interventions has helped to saved millions of lives and are through vaccines, strengthen the cold-chain infrastructure to 0 the result of 16 years of incredible commitment by countries ensure the delivery of safe and effective vaccines, and train 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Logotype with strapline and our many dedicated Measles & Rubella Initiative (M&RI) vaccinators and community volunteers to create and sustain partners. Yet, the lives of 20. 8 million unvaccinated children the demand for vaccines. are still in danger from measles – a disease completely Color preventable with two doses of a safe, life-saving vaccine The $10 million outbreak response funds M&RI receives each costing less than $2 per child per dose and that has been year from Gavi, the Vaccine Alliance, must be similarly used used for 50 years. Every $1 invested results in $58 of for a wide range of purposes. M&RI must apply these funds M&RI Donors in 2016 Use of M&RI Funds in 2016 cost savings. Over half of the children at risk come from 6 not only to stop the ongoing circulation of deadly viruses, countries – India (3. 2 million), Nigeria (3 million), Pakistan but also to ensure that if a disease is introduced, it does not (2 million), Indonesia (1. 5 million), Ethiopia (0. 7 million), and begin to circulate – that’s outbreak prevention, as well as Black the Democratic Republic of the Congo (0. 6 million). outbreak response. UNICEF 2015 carry over Shot@Life via Outbreak Response – Bundled Measles Vaccine, 8% (OB), 0% (USD 194,369) UNF, 7% Technical Assistance, 22% Tragically, each year measles causes more than 100,000 M&RI must also strategically prepare for improving surveillance Prince Alwaleed Outbreak Response – GAVI via UNF, deaths and congenital rubella syndrome afflicts more than in light of the fact that 70% of our measles and rubella direct UNICEF, 21% Operational Costs, 3% 21% 100,000 babies. Globally, the percentage of children receiving surveillance efforts are supported by human and financial the first dose of measles vaccine has remained at 85% since resources funded by polio eradication. While we prepare SIAs – Bundled Measles Vaccine, 2009, and only 64% of children are receiving the recommended for a global celebration of a polio-free planet forever, we Reverse 6% two doses of measles vaccine. In addition, only 47% are face diminishing polio funds. Those countries with the most receiving rubella vaccine. We must urgently ramp up our measles deaths are the same countries that rely heaviest on CDC direct to Total USD Total USD UNICEF, 6% efforts to meet our goals of eliminating measles and rubella. polio dollars. We must protect our achievements in measles 48,463,023 37,493,594 and rubella to ensure that another 135,000 lives are saved in American Red Cross via UNF, 3% Reaching these goals will take political commitment, partner- 2017, as were saved in 2016. ship, and financial investment. M&RI must work harder Project Perpetual via UNF, 2% to strengthen national platforms that deliver the first and The Measles & Rubella Initiative Church of Latter Day SIAs – second dose of measles or measles-rubella vaccine on Reverse Saints via UNF, 2% Operational, 20% time to every child, regardless of where he or she lives. This www.MeaslesRubellaInitiative.org with part CDC via UNF, 8% requires empowering our frontline health workers and @MeaslesRubella @ 50% CDC direct to WHO, 30% Surveillance, 18% transparent TheMeasles & Rubella Initiative Logo Specication for eect Logotype with “disappearing dots” Approximately two-thirds of 2016 Grant awards were made available to WHO and UNICEF in Q3 and Q4 2016 which resulted in postponement of some of the Color Red color specication R:196 C:0 planned activities to Q1 2017. Therefore, 95% of the $10.97 million unspent balance from 2016 was fully utilized by end Q1 2017. G:20 M:100 B:37 Y:90 K:20 Black 1 https://www.nytimes.com/2014/06/03/world/americas/ciro-de-quadros-74-dies-epidemiologist-who-championed-polio-immunizations.html?_r=0 200200 Clear space to leave around logo x Reverse x square height = x F_WHO1007_MeaslesInitiative AR_mech.indd 1-3 8/1/17 11:43 AM 150150 x x Reverse with dots @ 50% transparent for eect 100100 Logotype with strapline Color 5050 Black 00 20012001 20022002 20032003 20042004 20052005 20062006 20072007 20082008 20092009 20102010 20112011 20122012 20132013 20142014 20152015 20162016 Reverse Reverse with part @ 50% transparent for eect The countries with the largest number of reported 2016 IN NUMBERS measles cases in 2016: 153 (79%) countries provide rubella vaccine in their national Romania immunization schedule with 154,830 Mongolia 162 (83.5.%) measles cases 10 countries expected to 2,435 30,273 countries provide reported Ethiopia introduce in 2017 New Donor, Measles Second Dose globally 4,579 Alwaleed Philanthropies in their national immunization contributes $50 million schedule (2016–2020) to UNICEF to support global measles and China rubella elimination UNICEF procured Nigeria 24,820 and delivered 17,136 235,010,920 135,356,926 doses of measles-containing children vaccinated $5.4 million vaccines on behalf of DR Congo Indonesia against measles or spent in four countries utilizing 76 countries in 2016 22,162* measles-rubella Outbreak Response Fund (ORF) – 6,396 in 48 countries Cambodia, Kenya, Nigeria and Sierra Leone. The ORF helped Pakistan vaccinate more than 2,703 Strategic Advisory 8.9 million children India Group of Experts Somalia under emergency 17,250 (SAGE) endorsed the 5,657** conditions Midterm Review of the Global Measles 6,267 & Rubella Strategic Data source (unless otherwise indicated): measles cases reported to WHO * Data source: SITUATION EPIDEMIOLOGIQUE DE LA ROUGEOLE EN RDC (weekly measles bulletin) volunteers Plan 2012–2020 in ** Data source: Somali EPI/POL Weekly Update (weekly polio bulletin) mobilized by October 2016 American Hong Kong, city of 7 Red Cross Supplementary For the past 3 years, the million, achieves & Immunization Activity routine immunization work 1,200 measles- (SIA) Tool info – New tools group (one of 6 M&RI work Kenyan Lions members and guidance have been groups) has been providing Planning and Implementing free status High-Quality Supplementary Immunization Activities developed to ensure high input and advocating to build or strengthen 128,539 involved in road show in for Injectable Vaccines Using an Example of Measles and measles samples Kenya during MR campaign: in 2016 Rubella Vaccines quality campaigns. M&RI platforms to vaccinate in the Second Year tested 18 days covering most remote has increased efforts to of Life (2YL). Over 12 partners are engaged in this We are places 1,770 kms – reaching Field Guide promote use of this tool work group. 109,237 when planning planning and rubella samples 35 communities Ethiopia, Ghana, Malawi, Philippines and Zambia F_WHO1004_SIA Field Guide-mech_SpiralBindingCC17-2.indd 2 2/15/17 10:08 AM implementing SIAs. Seventy tested wiping out have helped contribute to our understanding of how percent of the African countries which have In September 2016, to best build strong platforms. This effort transforms conducted SIAs in 2016, have used the readiness the virus! the regional verification immunization delivery from the 1970’s model by Labnet shows there are only assessment tool to ensure adequate preparedness commission declared the serving to accommodate the increasing number of 6 measles genotypes remaining prior to starting the SIAs.
Load more

Recommended publications
  • Independent Monitoring Board of the Global Polio Eradication Initiative Report
    Independent Monitoring Board of the Global Polio Eradication Initiative Report July 2011 Independent This second report follows our third meeting, held in London on 30 June and 1 July 2011. Monitoring Board of the At present the needs are: Global Polio • To concisely understand the global situation Eradication Initiative • To maintain clear and energetic focus in each country with ongoing transmission July 2011 • To see the wood for the trees in identifying and dealing with the programme’s key risks • To find innovative solutions that break through entrenched problems • To surface fundamental problems that need urgent attention We are grateful to the many partners of the Global Polio Eradication Initiative who have provided us with information, logistical support, and valuable insights. We are grateful for their help, and commend their commitment. Our role remains to speak with a clear, objective voice that is independent of any of these partners. We each sit on this board in a personal capacity. We remain resolutely independent, and will continue to present our frank view without fear or favour. Sir Liam Donaldson (Chair) Dr Mushtaque Chowdhury* Former Chief Medical Officer, England Associate Director, Rockefeller Foundation Dr Nasr El Sayed Dr Ciro de Quadros Assistant Minister of Health, Egypt Executive Vice President, Sabin Vaccine Institute Dr Jeffrey Koplan Dr Sigrun Mogedal Vice President for Global Health Special Advisor, Norweigan Knowledge Centre Director, Emory Global Health Institute for the Health Services Professor Ruth Nduati Dr Arvind Singhal Chairperson, Department of Paediatrics and Child Health Marston Endowed Professor of Communication University of Nairobi University of Texas at El Paso Professor Michael Toole Head, Centre for International Health *Dr Chowdhury was unable to participate in the meeting but Burnet Institute, Melbourne endorses this report The Independent Monitoring Board was convened at the request of the World Health Assembly to monitor and guide the progress of the Global Polio Eradication Initiative’s 2010-12 Strategic Plan.
    [Show full text]
  • THE ERADICATION of POLIOMYELITIS (Fhe Albert V.• Sabin Lecture)
    THE ERADICATIONOF POLIOMYELITIS (fhe Albert V.•Sabin Lecture) by Donald Henderson, M.D., M.P.H. University Distinguished Service Professor The JohnsHopkins University Baltimore, Maryland 21205 Cirode Quadros, M.D., M.P.H. Regional Advisor Expanded Programme on lmmunii.ation Pan American Health Organization 525 23rd Street, N. W. Washington, D.C. 20037 Introduction The understanding and ultimate conquest of poliomyelitis was Albert Sabin's life­ long preoccupation, beginning with his earliest work in 1931. (Sabin and Olitsky, 1936; Sabin, 1965) The magnitude of that effort was aptly summarized by Paul in his landmark history of polio: "No man has ever contributed so much effective information - and so continuously over so many years - to so many aspects of poliomyelitis." (Paul, 1971) Thus, appropriately, this inaugural Sabin lecture deals with poliomyelitis and its eradication. Polio Vaccine Development and Its Introduction In the quest for polio control and ultimately eradication, several landmarks deserve special mention. At the outset, progress was contingent on the development of a vaccine and the production of a vaccine, in turn, necessitated the discovery of new methods to grow large quantities of virus. The breakthrough occurred in 1969 when Enders and his colleagues showed that large quantities of poliovirus could be grown in a variety of human cell tissue cultures and that the virus could be quantitatively assayed by its cytopathic effect. (Enders, Weller and Robbins, 1969) Preparation of an inactivated vaccine was, in principle, a comparatively straightforward process. In brief, large quantities of virus were grown. then purified, inactivated with formalin and bottled. Assurance that the virus had been inactivated could be demonstrated by growth in tissue.
    [Show full text]
  • Leadership in Global Health: the Case of Ciro De Quadros, a Testament to Values, Valor, and Vision
    Pan American Journal Profile of Public Health When Dr. Bill Foege wrote “When Words Fail,” he was referring to how difficult Leadership in it was for him to describe adequately, in written words, all the effort that is involved from the scientific conceptualization of a new vaccine, to eventual bench discovery global health: and development, to the training and supply chain logistics, and ultimately to the moment the needle pricks the skin to save a life of a child (1). He called it the “chain the case of Ciro of perfection”. He was “at a loss” to describe this cascade of events with due justice. I have been asked to describe the leadership attributes of Dr. Ciro de Quadros as a de Quadros, a case study in best practice and lessons to be learned. Similarly, I too am at a loss. Simply put, Ciro broke the mold. testament to I should disclose that what I am about to write is influenced by decades of either working directly for Ciro, as was the case during the polio eradication era in the Americas, to collaborating with Ciro more recently on various projects that in- values, valor, cluded measles and rubella elimination, the introduction of new vaccines, and sur- veillance of infectious diseases. The work evolved into a relationship that bridged and vision from professional mentorship, to actual friends with a deep sense of admiration, love, and mutual respect. In global health, leadership is somewhat like the “self-actualization” of public Jon Kim Andrus1 health practice. The “leader” must have all those attributes that embodies a fully realized individual, positioned in the system to make things happen, such as in Ciro’s case, to help create a world of equitable access to life-saving vaccines.
    [Show full text]
  • 2010 Albert B. Sabin Gold Medal Awarded to Dr. John D. Clemens
    Home About Us Press Room Support Sabin Michael Marine May 2010 Appointed CEO of The Sabin Report | Volume 12 Issue 2 Sabin Vaccine Institute 2010 Albert B. Sabin Gold Medal Awarded to Dr. John D. Clemens During a ceremony at The George Washington University City View Room, Dr. John D. Clemens, Director General of the International Vaccine Institute in Seoul, Korea, received the 2010 Albert B. Sabin Gold Medal Award for his contributions to reducing suffering and promoting peace Dr. Steven Knapp, The George Washington through the development, University President; Dr. John D. Clemens; evaluation, and distribution of and Dr. Peter Hotez, Sabin President and Michael W. Marine, former The George Washington University vaccines. Distinguished Research Professor US Ambassador to the Socialist Republic of Dr. Clemens led the first efficacy trial of an oral vaccine against Vietnam, was appointed as cholera, and conducted additional research on a measles vaccine as the new chief executive a research scientist at the International Center for Diarrhoeal Disease officer of the Sabin Research, Bangladesh during the 1980s. IVI scientists transferred Vaccine Institute on April the technology for the cholera vaccine to Shantha Biotechics of 28, announced Sabin's Hyderabad, India, and in 2009, Shanchol™ was licensed for Chairman of the Board of development. Trustees, Mort Hyman and President Dr. Peter Hotez. Through his stewardship at the International Vaccine Institute in Seoul, Korea where he has served as Director General since 1999, Marine joined Sabin's Dr. Clemens has engaged in vaccine diplomacy in many areas, leadership team in including the Democratic People's Republic of Korea Program, which December 2009 after aims to reduce the disease burden of Hib and Japanese encephalitis serving eight months on in North Korean children by providing technical assistance in the Joint Action Committee laboratory diagnosis and surveillance of these diseases and in the of the Global Network for introduction of vaccines to prevent them.
    [Show full text]
  • (GIN) Global Immunization News
    Global Immunization News (GIN) Global Immunization News (GIN) May 2019 In this issue News You can click on the article 72nd World Health Assembly Special Report you are interested in and ac- Hayatee Hasan, WHO Headquarters cess it directly! This year’s World Health Assembly was held from 20 News to 28 May 2019 at the Palais des Nations in Geneva, • Immunization Agenda 2030 2 Switzerland and was attended by nearly 4000 delegates • Advancing digital health in 2 from WHO’s 194 Member States and partner organiza- Bangladesh through electron- ic immunization registration tions. The general theme of this year’s World Health • The world’s first malaria 3 Assembly (WHA) was "Universal health coverage: leav- vaccine highlighted at ing no-one behind”. #WHA72 The Assembly Hall at the Palais des Nations 3 in Geneva, Switzerland. • Malaria vaccine pilot Key highlights included: launched in Ghana • WHO announced the appointment of four new goodwill ambassadors from the fields of sports, • Over 100 000 people sick 3 with measles in 14 months: politics and community mobilization to promote healthier lives, stronger health workforces and with measles cases at an improved mental health globally. The new ambassadors are: alarming level in the Europe- 1. Alisson Becker, goalkeeper of the Brazilian national and Liverpool football teams; an Region, WHO scales up 2. Dr Natália Loewe Becker, medical doctor and health advocate from Brazil, as WHO response Goodwill Ambassadors for Health Promotion; • WHO adapts ebola vaccina- 4 tion strategy in the Demo- 3. Cynthia Germanotta, President of Born This Way Foundation, which was co-founded cratic Republic of the Congo with her daughter Lady Gaga, as WHO Goodwill Ambassador for Mental Health; and to account for insecurity and 4.
    [Show full text]
  • Paving the Way for Immunization
    Paving the Way for Immunization XX Meeting of the Technical Advisory Group on Vaccine- preventable Diseases (TAG) 17-19 October 2012 Final Report 1 TECHNICAL ADVISORY GROUP ON VACCINE‐PREVENTABLE DISEASES XX MEETING: “PAVING THE WAY FOR IMMUNIZATION” Washington DC, 17‐19 October 2012 Members 2012 Dr. Ciro A. de Quadros Executive Vice President President Sabin Vaccine Institute Washington, D.C., United States Dr. Akira Homma Chairman Policy and Strategy Council, Bio ‐Manguinhos Institute Rio de Janeiro, Brazil Dr. Anne Schuchat Director National Center for Immunization and Respiratory Diseases (NCIRD) Centers for Disease Control and Prevention Atlanta, GA, United States Dr. Arlene King Chief Medical Officer Ministry of Health and Long‐term Care Ontario, Canada Dr. Jeanette Vega Managing Director Foundation Initiatives The Rockefeller Foundation New York, NY, United States Dr. José Ignacio Santos Preciado Professor Department of Experimental Medicine Head of Clinical Research Research Division School of Medicine, Universidad Nacional Autónoma de México (UNAM) Mexico City, Mexico _________________________________________________________________________________ 2 XX TAG Meeting, Washington DC, 2012 – Final Report Dr. Peter Figueroa (unable to attend) Chief Medical Officer Ministry of Health Kingston, Jamaica Dr. Ramiro Guerrero‐Carvajal (virtual participation) Director Research Center for Social Protection and Health Economy (PROESA) Cali, Colombia Roger Glass Director Fogarty International Center, NIH/JEFIC‐National Institutes of Health
    [Show full text]
  • Global Outlook-Endgame-V10.Indd 63 12/10/13 1:05 PM HOW to END POLIO
    A ROTARY PRIMER GLOBALOUTLOOK A ROTARIAN’S GUIDE TO THE RACE TO END POLIO COPYRIGHT © 2014 BY ROTARY INTERNATIONAL. ALL RIGHTS RESERVED. Global Outlook-EndGame-v10.indd 63 12/10/13 1:05 PM HOW TO END POLIO hat does it mean to “end polio”? Zero reported cases around the globe is the goal, but that’s not all it will take to ensure that the world remains polio-free forever. The Global Polio Eradication WInitiative (GPEI) details the long-term plan to eradicate polio by 2018 in its endgame strategy. In this issue, we speak with Ciro de Quadros, an expert on public health, about the final stage of polio eradication; review the four objectives of the endgame strategy; investigate what we’re doing to address the challenges to ending polio; and explain surveillance, a critical step in determining when polio is gone for good. What is your part? Read on to find out how you can help finish the job. 64 THE ROTARIAN | FEBRUARY 2014 Global Outlook-EndGame-v10.indd 64 12/10/13 1:05 PM EXPERT ANALYSIS A CONVERSATION WITH CIRO DE QUADROS EXECUTIVE VICE PRESIDENT OF THE SABIN VACCINE INSTITUTE iro de Quadros is one of the world’s Pakistan. With the last election in Pakistan, it is not known leading authorities on public how the new government will solve these problems. health. An epidemiologist, he led the eradication of smallpox in In the 1980s, you led the efforts to eliminate polio through Ethiopia and the elimination of the immunization program of the Pan American Health polio, measles, and rubella in the Organization (PAHO).
    [Show full text]
  • Sabin Vaccine Report
    Volume VIII, Number 1 Sabin Vaccine Spring 2005 EPORT The newsletter of the Albert B. Sabin Vaccine InstituteR — dedicated to disease prevention www.sabin.org FDA Clears Human Hookworm Vaccine for Phase I Safety Trials Sabin/GW Researchers Receive Word on Investigational New Drug Status for Vaccine Clinical trials to test the safety of a gin safety trials is a major milestone for in individuals who suffer from hook- first-of-its-kind human hookworm vac- the human hookworm vaccine project,” worm infection.” cine will begin in the Washington, DC Hotez said. “It has taken an amazing Human hookworm infection is caused area in the coming weeks after the U.S. amount of our team’s effort to get us to by parasitic worms that fasten onto the Food and Drug Administration conferred the current stage of vaccine develop- inner layers of the small intestine using investigational new drug status on the ment. Of course, our ultimate goal is to their teeth-like projections and cause vaccine this past January. No current take this research to developing coun- blood loss at the attachment site. vaccine is available to prevent hook- tries where the vaccine will be tested Hookworm disease refers to the iron worm disease, which is one of the most Continued on page 4 common chronic infections of humans with an estimated 740 million cases in The village of Americaninhas, areas of rural poverty in the tropics in a rural part of Minas Gerais and subtropics. state in Brazil, is the focus of a The Human Hookworm Vaccine Ini- field study of hookworm dis- tiative (HHVI) is sponsored by the ease burden, being conducted Albert B.
    [Show full text]
  • TRIBUTE to a CHAMPION: Ciro De Quadros Ciro Was a Brazilian
    TRIBUTE TO A CHAMPION: Ciro de Quadros Ciro was a Brazilian Pediatrician that left his country very early, on the seventies to build up an outstanding career as a leader in WHO. He was a champion in immunization and among his many major achievements was the strategy that led to the virtual eradication of Polio in Latin America. Although he was a legend in Brazil I only got to meet him face to face in 2004, when he was invited to join us at the International Pediatric Association. Ciro chaired our Technical Advisory Group in Immunization, working closely with our Past President Prof. Adenike Grange. Recently, on 2013, we had the opportunity to work together in Nepal in a workshop to empower National Pediatric Societies in developing countries to initiate or to boost local immunization programs. It is sad to learn from his passing away but, ultimately we all shall die. Most important is how we spend our lives. Ciro devoted his to a passionate struggle for reducing the burden of disease and improving health worldwide. We honor him as one of the most important players in Global Child Health, an example to be followed and a good friend. We’ll miss him. Sergio Cabral Immediate Past President of the IPA In January, 2011, Ciro and I were appointed as co-chairs of the Technical Advisory Group on Immunisation (TAGI) by Sergio Cabral who was then (2010-2013) the President of the International Paediatric Association (IPA). I was at that time serving as the IPA representative on GAVI's Steering Committtee of Civil Societies' Organisations on Immunisation.
    [Show full text]
  • In the Mood for Wiping out Vaccine-Preventable Diseases Ciro De Quadros Has Led Some of the Most Successful Immunization Campaigns in the History of Public Health
    News In the mood for wiping out vaccine-preventable diseases Ciro de Quadros has led some of the most successful immunization campaigns in the history of public health. He tells Fiona Fleck why, in some ways, it’s harder to eliminate vaccine-preventable diseases today than it was in the past. Q: How did you become interested in immunization? Ciro de Quadros is the executive vice president of the A: After I got my MD degree in Sabin Vaccine Institute, where he heads the vaccine 1966, I worked at a health centre in a advocacy and education programme. Before he small town in the Amazon region, then took up that post in 2003, he held leading positions studied epidemiology and got involved in immunization at the World Health Organization in a new national centre for epidemiol- ogy, a kind of “Brazilian CDC” (Centers (WHO)/Pan American Health Organization (PAHO) for Disease Control and Prevention). between 1970 and 2002, including as the first head But the centre never took off because of the American region’s Expanded Programme on Courtesy of Ciro de Quadros Courtesy of Ciro people working there were accused Ciro de Quadros Immunization. From 1970 to 1976, he served as WHO’s of being communists by the military chief epidemiologist for the smallpox programme in dictatorship. Through the centre, I got Ethiopia. He holds several academic posts, has published extensively in peer- involved in the smallpox campaign reviewed journals on immunization and related issues and serves on many expert which had started in Brazil. health committees. He completed his medical and public health studies in Brazil.
    [Show full text]
  • Acknowledgements & Contacts
    page 144 Global Vaccine Action Plan Acknowledgements & Contacts page 145 Acknowledgements & Contacts Approximately 1,100 participants from more than 140 countries and 290 organizations provided ideas, feedback, and comments to the Global Vaccine Action Plan. This document was developed under the auspices of the Decade of Vaccines Collaboration Leadership Council, composed of Seth Berkley (GAVI Alliance), Margaret Chan (World Health Organization), Christopher Elias (Bill & Melinda Gates Foundation), Anthony Fauci (US National Institute of Allergy and Infectious Diseases), Anthony Lake (UNICEF), and 5. Joy Phumaphi (African Leaders Malaria Alliance). page 146 Global Vaccine Action Plan Acknowledgements & Contacts page 147 the deCade of vaccines Collaboration Indonesia), Gina Tambini (the Pan Susan McKinney (USAID), Robert Alliance), Lauren Franzel (PATH), Jennifer Kates (Kaiser Family Research Institute), Adam Sabow steering CoMMittee guided the American Health Organization), Jos Steinglass (John Snow, Inc.), Björn Gillsater (UNICEF), Amanda Foundation), Kaia Lenhart (GMMB), (McKinsey & Company), Chris Wilson deveLopment of the GVAP: Vandelaer (co-chair Delivery Working Liang Xiaofeng (Chinese CDC), Glassman (Center for Global Jesus Lopez-Macedo (UNICEF), (Bill & Melinda Gates Foundation). Pedro Alonso (co-chair DoVC Steering Group, UNICEF), and Sandy John Wecker (PATH), Simon Wright Development), Shanelle Hall Adrian Lovett (ONE), Maziko Matemba Around 110 individuals participated in Committee, the Barcelona Institute Wrobel (co-chair Global
    [Show full text]
  • SNE3603.Pdf (3.443Mb)
    Volume XXXVI Number 3 Immunize and Protect Your Family June 2014 Ciro de Quadros Honored as a PAHO Public Health Beloved Dr. Ciro de Hero of the Americas Quadros, 1940-2014 Dr. Ciro de Quadros, was honored on 25 April, 2014 as a “Public Health Hero of the Americas” by the Pan American Health Organization/World Health Organization (PAHO/WHO). Ciro de Quadros accepted the award from PAHO/WHO Director Carissa F. Etienne during an international vaccine symposium marking the 20th anniversary of the Sabin Vaccine Institute, where Ciro de Quadros was Executive Vice President and Director of Vaccine Advocacy and Education until the day of his death. “Ciro’s long and distinguished career in public health not only coincided with but indeed accelerated the growing use of vaccines to save lives and eliminate diseases in the Americas and beyond,” said Dr. Etienne in honoring Ciro de Quadros. “We at PAHO believe that no single person has done more to extend the benefits of immunization to people throughout the Americas.” "I am deeply honored to be recognized by PAHO and to have been part of Latin America's immunization efforts,” said Ciro de Quadros. In the late 1970s, Dr. de DR. CIRO DE QUADROS, 1940-2014 Quadros founded the Expanded Program on Immunization (EPI) at On 28 May this year, we lost a PAHO, which encour- visionary, a mentor, and a friend, aged and supported and one of the people that the countries of Latin contributed most extraordinarily America and the to the world of global immuniza- Caribbean in making tion.
    [Show full text]